September 24, 2025 - 08:58

Micron Technology has reported impressive financial results for the fourth quarter and the full year of fiscal 2025, showcasing remarkable growth fueled by the increasing demand for AI data centers. The company achieved a revenue of $11.32 billion in the fourth quarter, a significant increase from $9.30 billion in the previous quarter and $7.75 billion during the same period last year.
The strong performance highlights the company's ability to capitalize on the rapidly growing AI sector, which has become a crucial driver of revenue. Micron's GAAP net income for the quarter demonstrated substantial growth, reflecting the robust demand for memory and storage solutions essential for AI applications.
Looking ahead, Micron forecasts an additional $1.2 billion in sequential revenue growth for the upcoming quarter, with gross margins expected to exceed 50%. This optimistic outlook underscores the company's confidence in sustaining its growth trajectory, particularly as AI technologies continue to advance and proliferate across various industries.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...